Infertility and borderline malignant ovarian tumors: a case of successful pregnancy after fertility-preserving management of the disease

For women of reproductive age diagnosed with gynaecologic cancers, techniques that aim to preserve the fertility are a growing area of research. Fertility-sparing surgical techniques should be an option for these patients, since removing the abnormal ovarian tissue may restore conceiving potential. The authors present the case of a 26-year-old woman diagnosed incidentally with a borderline ovarian tumor during an infertility check-up, who obtained a spontaneous pregnancy two months after laparoscopic unilateral adnexaectomy, followed by IVF and embryo-banking.

Infertility; Borderline ovarian tumor; Fertility-sparing surgery; Pregnancy; Low malignant potential; IVF.

[1] Practice Committee of the American Society for Reproductive Medicine: “Testing and interpreting measures of ovarian reserve: a committee opinion”. Fertil. Steril., 2015, 103, e9.

[2] Eniola O.W., Adetola A.A., Abayomi B.T.: “A review of Female Infertility; important etiological factors and management”. J. Microbiol. Biotech. Res., 2012, 2, 379.

[3] Dean D.D., Agarwal S., Tripathi P.: “Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages”. J. Assist. Reprod. Genet., 2018, 35, 2121.

[4] Abrao M.S., Muzii L., Marana R.: “Management of Infertility Today: Proceedings of a Workshop sponsored by the Pontifical Academy for Life”. Inter. J. Obstet. Gynaecol., 2013, 123, S18.

[5] Morice P., Denschlag D., Romolakis A., Reed N., Schneider A., Kesic V., Colombo N.: “Recommendations of the fertility task force of the European Society of Gynaecologic Oncology about the conservative management of ovarian malignant tumors”. Int. J. Gynecol. Cancer, 2011, 21, 951.

[6] Tavassoli F.A., Devilee P.: “World Health Organisation classification of tumors. Pathology and genetics”. Tumors of the breast and female genital organs. Lyon: IARC Press, 2003

[7] Morice P., Camatte S., El Hassan J., Lhomme AC., Duvillard P., Castaigne D.: “Clinical outdomes and fertility results after conservative treatment for ovarian borderline tumor”. Fertil. Steril., 2001, 75, 92.

[8] Gershenson D.M.: “Clinical management of potential tumors of low malignancy”. Clin. Obstet. Gynecol., 2002, 16, 513.

[9] Harris R., Whittemore A., Itnyre J., Collaborative Ovarian Cancer Group: “Characteristics relating to ovarian risk: a collaborative analisys of 12 US case-control studies. Epithelial tutors of low malignant potential in white women”. Am. J. Epidemiol., 1992, 136, 1204.

[10] Riman T., Dickman P.W., Nilsson S., Correia N., Nordlinder H., Magnusson C.M.: “Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study”. Gynecol. Oncol., 2001, 83, 575.

[11] Winter W.E. 3rd., Kucera P.R., Rodgers W., McBroom J.W., Olsen C., Maxwell G.L.: “Surgical staging in patients with ovarian tutors of low malignant potential”. Obstet. Gynecol., 2002, 25, 2928.

[12] Zanetta G., Rota S., Chiari S., Bonari C., Bratina G., Mangioni C.: “Behavior of borderline tutors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study”. J. Clin. Oncol., 2001, 19, 2658.

[13] Seracchioli R., Venturoli S., Colombo F.M., Govoni F., Missiroli S., Bagnoli A.: “Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors”. Fertil. Steril., 2001, 76, 999.

[14] Chang HJ., Han S.H., Lee L.R.: “Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels”. Fertil. Steril., 2010, 94, 343.

[15] Iwase A., Hirokawa W., Goto M.: “Serum anti-Müllerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve”. Fertil. Steril., 2010, 94, 2846.

[16] Doroftei B., Mambet C., Zlei M.: “It’s Never over until It’s over: How Can Age and Ovarian Reserve Be Mathematically Bound through the Measurement of Serum AMH—A Study of 5069 Romanian Women”. PLoS One, 2015, 10, e0125216.

[17] Somigliana E., Ragni G., Benedetti F.: “Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles”. Hum. Reprod., 2003, 18, 2450.

[18] Ho H.Y., Lee R.K.K., Hwu Y.M., Lin M.H., Su J.T., Tsai Y.C.: “Poor Response of Ovaries with Endometrioma Previously Treated with Cystectomy to Controlled Ovarian Hyperstimulation”. J. Assist. Reprod. Genet., 2002, 19, 507.

[19] Fauvet R., Poncelet C., Boccara J., Descamps P., Fondrinier E., Darai E.: “Fertility after conservative treatment of borderline ovarian tumors: a french multicenter study”. Fertil. Steril., 2005, 83, 284.

[20] Morris R.T., Gershenson D.M., Silva E.G., Fallen M., Morris M., Wharton J.T.: “Outcome and reproductive function after conservative surgery for borderline ovarian tumors”. Obstet. Gynecol., 2000, 95, 541.

[21] Nicolaiciuc D., Simionescu G., Doroftei B., Anton SC., Bolota M., Ioanid N., et al.: “Abdominal radical trachelectomy as a method of preserving fertility in patients with cervical cancer”. Med. Rev. Chir., 2018, 122, 96.

[22] Kardakis S.: “Fertility-preserving surgery in patients with early stage cervical carcinoma”. ISRN Oncol., 2012, 2012, 817065..

[23] Mitildzans A., Bazarova J., Brikune J., Gelderina E., Isajevs S., Lakutins J., et al.: “First Successful Full Term Pregnancy Outcome in Latvia Following a Radical Trachelectomy for the Patient with a Combined Pathology of a Cervical Cancer and Severe Subfertility”. Acta Chir Latviensis, 2016, 16, 44.